Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AFLIBERCEPT
- caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.
- Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
- Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
- Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)
- Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
- A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macu
- Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Efficacy and Safety of RC28-E Versus Aflibercept
- Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E
- A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)
- Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy
- Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
- Safety Study of Zimura™in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD
- Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer
- A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema
- A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment
- A Study of Longer Interval of IVT IBI302 in Subjects With nAMD
- Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)
- A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)
- Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema
- Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema
- Ranibizumab Versus Aflibercept for CRVO in Young Patients.
- Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit
- Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
- Adjunct Episcleral Brachytherapy for PCV
- Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe
- A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
- A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.
- Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
- A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)
- BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema
- Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD
- Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration
- BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration
- Ozurdex in Suboptimal Diabetic Macular Edema Patients
- Non-Responsive Diabetic Macular Edema and Spironolactone
- A Study of IBI302 in Patients With nAMD
- Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer
- Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections
- PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
- Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial
- Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept
- Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye
- Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
- Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)
- A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration
- Treat-and-extend Using Aflibercept for Type 3 Neovascularization
- Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO
- A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
- A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
- An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study
- A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
- A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema
- Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair
- A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
- Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections
- Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration
- A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
- A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
- A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Combination of Ranibizumab and Targeted Laser Photocoagulation
- Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
- Study to Gather Information on Safety and Use of High Dose Aflibercept Injection Into the Eye in Patients With an Age Related Eye Disorder That Causes Blurred Vision or a Blind Spot Due to Abnormal Blood Vessels That Leak Fluid Into the Light Sensit
- Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema
- TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.
- Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients
- A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
- Anti-VEGF Therapy for Acute Thyroid Eye Disease
- Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)
- Use of Ziv Aflibercept in Different Retinal Diseases
- Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan
- Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept
- A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]
- A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration
- Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage
- Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
- Treat and Extend Analysis Trial With Aflibercept in Wet-AMD
- The Sahlgrenska Anti-VEGF Study
- Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
- Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)
- Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid
- To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
- A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
- Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration
- Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema
- Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
- Anti-VEGF Therapy Versus Dexamethasone Implant for DME
- The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial)
- One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab
- A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD
- Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
- Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema
- Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1
- A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
- Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
- Effect Aflibercept on Ocular Perfusion
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion
- Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
- Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
- Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.
- Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)
- Nutraceutical Support With Omega-3
- Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
- Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema
- Navigated Laser In Branch Retinal Vein Occlusion Study
- Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injecti
- CLN-0046: Treatment of AMD Subjects With OTX-TKI
- Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
- A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
- A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
- Intense Treatment Regimen With Intravitreal Aflibercept Injection
- Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
- Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
- RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients
- A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2 in Patients With Advanced Solid Tumors
- A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept
- Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
- Ziv-aflibercept Efficacy in Better Regulating AMD
- Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion
- Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept
- Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD
- ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
- Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3
- IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab
- DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
- Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an
- Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
- Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer
- A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration
- Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME
- Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer
- Intravitreal Aflibercept for Submacular Hemorrhage
- Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
- An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
- Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
- Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
- Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
- mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer
- Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
- The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
- The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
- Episcleral Brachytherapy for the Treatment of Wet AMD
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
- Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
- Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms
- Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
- Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema
- Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema
- 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
- Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
- Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
- A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema
- Initial Versus Delayed PDT Combination With Conbercept in PCV
- Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece
- Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
- Study for Collection of Aflibercept Data in Routine Practice
- Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
- Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
- Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
- 3 Month Outcome of Ziv-aflibercept for DME
- Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema
- Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD
- Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
- Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
- Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
- EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection
- PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept
- Aflibercept in Recurrent or Persistent CNV
- Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
- Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
- The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema
- Mean Visual Acuity Changes Following Five Injections of Aflibercept
- Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
- CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab
- Anti-VEGF Treatment for Prevention of PDR/DME
- Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
- Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN
- Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment
- Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer
- Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy
- Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy
- Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy
- Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
- Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
- Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
- Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
- Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
- Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
- Intravitreal Injections of Ziv-aflibercept for Macular Diseases
- Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).
- Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen
- Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
- To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
- Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
- Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
- Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
- IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD
- Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
- Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
- VITAL - Individualising Therapy for Neovascular AMD With Aflibercept
- Efficacy and Safety of RTH258 Versus Aflibercept - Study 2
- Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)
- Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
- Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
- A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration
- Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
- Variable Interval Versus Set Interval Aflibercept for DME
- A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
- Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers
- Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment
- The Endurance 1 Trial
- Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME
- Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
- Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD
- Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)
- Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab
- Efficacy and Safety of RTH258 Versus Aflibercept - Study 1
- Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
- Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
- The Endurance 1 Trial
- Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients
- Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept
- Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy
- Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD
- Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen
- Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
- Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients
- Stereotactic Radiotherapy for Wet AMD (STAR)
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer
- Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD
- A Pharmacokinetic Study of Intravitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Wet Age-related Macular Degeneration (DRAW).
- Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
- Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer
- [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib
- A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.
- Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).
- Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I
- Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD
- Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
- Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
- Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
- Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)
- A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients
- Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer
- Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
- Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept
- Aflibercept in Polypoidal Choroidal Vasculopathy
- Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF
- Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)
- Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer
- A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer
- Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
- Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer
- Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer
- Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
- Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections
- Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
- Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
- Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.
- Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
- Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)
- Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy
- Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
- Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD
- Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient
- Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
- Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy
- A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies
- Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration
- Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.
- Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration
- Treatment for CI-DME in Eyes With Very Good VA Study
- Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor
- Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer
- A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
- Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
- NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
- Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea
- Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
- Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers
- Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration
- Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
- Aflibercept Injection for Proliferative Diabetic Retinopathy
- Efficacy and Safety Study of ESBA1008 Versus EYLEA®
- Treatment for Presumed Ocular Histoplasmosis
- Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines
- Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
- Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
- 5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
- FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
- A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes
- Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
- Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment
- Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
- Use of Eylea for the Treatment of an Optic Nerve Hemangioma
- Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
- The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
- Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies
- Colorectal Cancer Metastatic
- On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)
- Adjuvant Aflibercept for Metastatic Colorectal Cancer
- Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
- A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy
- Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results
- Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
- Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases
- Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
- Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
- Intravitreal Aflibercept Injection for Radiation Retinopathy
- Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
- Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- Study for Recalcitrant Age Related Macular Degeneration
- Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration
- Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)
- To Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMD
- Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment
- Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
- Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors
- Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)
- Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer
- A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients
- Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer
- S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact
- Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
- Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma
- Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer
- Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
- A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
- A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
- Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
- A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
- VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
- AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites
- Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
- Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
- Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer
- Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
- Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma
Clinical trials list
click for details